Circulating immune complexes in patients with melanoma

Area of Science:

• Immunology
• Oncology
• Biochemistry

Background:

• Immune complexes (ICs) play a role in various immune responses.
• Their presence and levels in melanoma patients require further investigation.

Purpose of the Study:

• To investigate the prevalence and significance of immune complexes in melanoma patients.
• To determine the correlation between IC levels and disease status.

Main Methods:

• Sera from 51 melanoma patients and 55 healthy donors were analyzed.
• The EA-rosette forming cell inhibition assay was used to detect immune complexes.
• A cut-off of 5% rosette inhibition was established.

Main Results:

• ICs were detected in 67.6% of melanoma patients versus 20% of healthy controls (p < 0.001).
• Higher IC prevalence was observed in patients with clinical symptoms (localized 80%, metastatic 78%) compared to those with no evidence of disease (60%).
• Mean inhibitory rates were higher in metastatic (21%) and localized (15.1%) disease compared to no evidence of disease (10%).

Conclusions:

• Elevated immune complex levels are significantly associated with melanoma.
• Increasing IC levels correlate with tumor dissemination and indicate a poorer prognosis.
• Stabilization of ICs at low levels suggests a favorable prognostic sign.